Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.

Published

Journal Article

The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and updated recommendations regarding systemic therapy for first-line and subsequent-line treatment of patients with hepatocellular carcinoma.

Full Text

Duke Authors

Cited Authors

  • Benson, AB; D'Angelica, MI; Abbott, DE; Abrams, TA; Alberts, SR; Anaya, DA; Anders, R; Are, C; Brown, D; Chang, DT; Cloyd, J; Covey, AM; Hawkins, W; Iyer, R; Jacob, R; Karachristos, A; Kelley, RK; Kim, R; Palta, M; Park, JO; Sahai, V; Schefter, T; Sicklick, JK; Singh, G; Sohal, D; Stein, S; Tian, GG; Vauthey, J-N; Venook, AP; Hammond, LJ; Darlow, SD

Published Date

  • April 1, 2019

Published In

Volume / Issue

  • 17 / 4

Start / End Page

  • 302 - 310

PubMed ID

  • 30959462

Pubmed Central ID

  • 30959462

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2019.0019

Language

  • eng

Conference Location

  • United States